 | • レポートコード：QYR2104Z3148 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌薬、抗ウイルス薬、抗真菌薬、駆虫薬）、用途別市場規模（病院/臨床検査室、参照検査室、学術/研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染症の市場動向 ・企業の競争状況、市場シェア ・感染症の種類別市場規模（抗菌薬、抗ウイルス薬、抗真菌薬、駆虫薬） ・感染症の用途別市場規模（病院/臨床検査室、参照検査室、学術/研究所、その他） ・感染症の北米市場規模2016-2027（アメリカ、カナダ） ・感染症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、Gilead Sciences、GlaxoSmithKline、Johnson & Johnson、Merck、Pfizer、AbbVie、Astellas Pharma、AstraZeneca、Bayer、Bristol-Myers Squibb、Chimerix Pharmaceuticals、Cubist、Eli Lilly、Isis Pharmaceuticals、Mitsubishi Tanabe Pharma、Novartis、Sanofi、Vertex） ・結論 |
When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.
Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.
Market Analysis and Insights: Global Infectious Diseases Market
The global Infectious Diseases market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Diseases market.
Global Infectious Diseases Scope and Market Size
Infectious Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Antiparasitic Drugs
Segment by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Astellas Pharma
AstraZeneca
Johnson & Johnson
Merck
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibacterial Drugs
1.2.3 Antiviral Drugs
1.2.4 Antifungal Drugs
1.2.5 Antiparasitic Drugs
1.3 Market by Application
1.3.1 Global Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals/Clinical Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic/Research Institutes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases Market Perspective (2016-2027)
2.2 Infectious Diseases Growth Trends by Regions
2.2.1 Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Diseases Industry Dynamic
2.3.1 Infectious Diseases Market Trends
2.3.2 Infectious Diseases Market Drivers
2.3.3 Infectious Diseases Market Challenges
2.3.4 Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases Players by Revenue
3.1.1 Global Top Infectious Diseases Players by Revenue (2016-2021)
3.1.2 Global Infectious Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases Revenue
3.4 Global Infectious Diseases Market Concentration Ratio
3.4.1 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Revenue in 2020
3.5 Infectious Diseases Key Players Head office and Area Served
3.6 Key Players Infectious Diseases Product Solution and Service
3.7 Date of Enter into Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases Breakdown Data by Type
4.1 Global Infectious Diseases Historic Market Size by Type (2016-2021)
4.2 Global Infectious Diseases Forecasted Market Size by Type (2022-2027)
5 Infectious Diseases Breakdown Data by Application
5.1 Global Infectious Diseases Historic Market Size by Application (2016-2021)
5.2 Global Infectious Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Diseases Market Size (2016-2027)
6.2 North America Infectious Diseases Market Size by Type
6.2.1 North America Infectious Diseases Market Size by Type (2016-2021)
6.2.2 North America Infectious Diseases Market Size by Type (2022-2027)
6.2.3 North America Infectious Diseases Market Size by Type (2016-2027)
6.3 North America Infectious Diseases Market Size by Application
6.3.1 North America Infectious Diseases Market Size by Application (2016-2021)
6.3.2 North America Infectious Diseases Market Size by Application (2022-2027)
6.3.3 North America Infectious Diseases Market Size by Application (2016-2027)
6.4 North America Infectious Diseases Market Size by Country
6.4.1 North America Infectious Diseases Market Size by Country (2016-2021)
6.4.2 North America Infectious Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Infectious Diseases Market Size (2016-2027)
7.2 Europe Infectious Diseases Market Size by Type
7.2.1 Europe Infectious Diseases Market Size by Type (2016-2021)
7.2.2 Europe Infectious Diseases Market Size by Type (2022-2027)
7.2.3 Europe Infectious Diseases Market Size by Type (2016-2027)
7.3 Europe Infectious Diseases Market Size by Application
7.3.1 Europe Infectious Diseases Market Size by Application (2016-2021)
7.3.2 Europe Infectious Diseases Market Size by Application (2022-2027)
7.3.3 Europe Infectious Diseases Market Size by Application (2016-2027)
7.4 Europe Infectious Diseases Market Size by Country
7.4.1 Europe Infectious Diseases Market Size by Country (2016-2021)
7.4.2 Europe Infectious Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases Market Size (2016-2027)
8.2 Asia-Pacific Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific Infectious Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific Infectious Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific Infectious Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Diseases Market Size (2016-2027)
9.2 Latin America Infectious Diseases Market Size by Type
9.2.1 Latin America Infectious Diseases Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Diseases Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Diseases Market Size by Type (2016-2027)
9.3 Latin America Infectious Diseases Market Size by Application
9.3.1 Latin America Infectious Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Diseases Market Size by Application (2016-2027)
9.4 Latin America Infectious Diseases Market Size by Country
9.4.1 Latin America Infectious Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases Market Size (2016-2027)
10.2 Middle East & Africa Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa Infectious Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa Infectious Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa Infectious Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Infectious Diseases Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Diseases Introduction
11.2.4 Gilead Sciences Revenue in Infectious Diseases Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Infectious Diseases Introduction
11.3.4 GlaxoSmithKline Revenue in Infectious Diseases Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Infectious Diseases Introduction
11.4.4 Johnson & Johnson Revenue in Infectious Diseases Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Infectious Diseases Introduction
11.5.4 Merck Revenue in Infectious Diseases Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Infectious Diseases Introduction
11.6.4 Pfizer Revenue in Infectious Diseases Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Infectious Diseases Introduction
11.7.4 AbbVie Revenue in Infectious Diseases Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Details
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Infectious Diseases Introduction
11.8.4 Astellas Pharma Revenue in Infectious Diseases Business (2016-2021)
11.8.5 Astellas Pharma Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Infectious Diseases Introduction
11.9.4 AstraZeneca Revenue in Infectious Diseases Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Infectious Diseases Introduction
11.10.4 Bayer Revenue in Infectious Diseases Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Infectious Diseases Introduction
11.11.4 Bristol-Myers Squibb Revenue in Infectious Diseases Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Chimerix Pharmaceuticals
11.12.1 Chimerix Pharmaceuticals Company Details
11.12.2 Chimerix Pharmaceuticals Business Overview
11.12.3 Chimerix Pharmaceuticals Infectious Diseases Introduction
11.12.4 Chimerix Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021)
11.12.5 Chimerix Pharmaceuticals Recent Development
11.13 Cubist
11.13.1 Cubist Company Details
11.13.2 Cubist Business Overview
11.13.3 Cubist Infectious Diseases Introduction
11.13.4 Cubist Revenue in Infectious Diseases Business (2016-2021)
11.13.5 Cubist Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Details
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Infectious Diseases Introduction
11.14.4 Eli Lilly Revenue in Infectious Diseases Business (2016-2021)
11.14.5 Eli Lilly Recent Development
11.15 Isis Pharmaceuticals
11.15.1 Isis Pharmaceuticals Company Details
11.15.2 Isis Pharmaceuticals Business Overview
11.15.3 Isis Pharmaceuticals Infectious Diseases Introduction
11.15.4 Isis Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021)
11.15.5 Isis Pharmaceuticals Recent Development
11.16 Mitsubishi Tanabe Pharma
11.16.1 Mitsubishi Tanabe Pharma Company Details
11.16.2 Mitsubishi Tanabe Pharma Business Overview
11.16.3 Mitsubishi Tanabe Pharma Infectious Diseases Introduction
11.16.4 Mitsubishi Tanabe Pharma Revenue in Infectious Diseases Business (2016-2021)
11.16.5 Mitsubishi Tanabe Pharma Recent Development
11.17 Novartis
11.17.1 Novartis Company Details
11.17.2 Novartis Business Overview
11.17.3 Novartis Infectious Diseases Introduction
11.17.4 Novartis Revenue in Infectious Diseases Business (2016-2021)
11.17.5 Novartis Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Details
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Infectious Diseases Introduction
11.18.4 Sanofi Revenue in Infectious Diseases Business (2016-2021)
11.18.5 Sanofi Recent Development
11.18 Vertex
.1 Vertex Company Details
.2 Vertex Business Overview
.3 Vertex Infectious Diseases Introduction
.4 Vertex Revenue in Infectious Diseases Business (2016-2021)
.5 Vertex Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibacterial Drugs
Table 3. Key Players of Antiviral Drugs
Table 4. Key Players of Antifungal Drugs
Table 5. Key Players of Antiparasitic Drugs
Table 6. Global Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Infectious Diseases Market Share by Regions (2016-2021)
Table 10. Global Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Infectious Diseases Market Share by Regions (2022-2027)
Table 12. Infectious Diseases Market Trends
Table 13. Infectious Diseases Market Drivers
Table 14. Infectious Diseases Market Challenges
Table 15. Infectious Diseases Market Restraints
Table 16. Global Infectious Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Infectious Diseases Market Share by Players (2016-2021)
Table 18. Global Top Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases as of 2020)
Table 19. Ranking of Global Top Infectious Diseases Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Infectious Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Infectious Diseases Product Solution and Service
Table 23. Date of Enter into Infectious Diseases Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Infectious Diseases Revenue Market Share by Type (2016-2021)
Table 27. Global Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Infectious Diseases Revenue Market Share by Application (2016-2021)
Table 31. Global Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Infectious Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Infectious Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Infectious Diseases Product
Table 66. F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Infectious Diseases Product
Table 71. Gilead Sciences Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 72. Gilead Sciences Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Infectious Diseases Product
Table 76. GlaxoSmithKline Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Infectious Diseases Product
Table 81. Johnson & Johnson Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Infectious Diseases Product
Table 86. Merck Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Infectious Diseases Product
Table 91. Pfizer Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. AbbVie Company Details
Table 94. AbbVie Business Overview
Table 95. AbbVie Infectious Diseases Product
Table 96. AbbVie Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Astellas Pharma Company Details
Table 99. Astellas Pharma Business Overview
Table 100. Astellas Pharma Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 101. Astellas Pharma Recent Development
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Infectious Diseases Product
Table 105. AstraZeneca Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 106. AstraZeneca Recent Development
Table 107. Bayer Company Details
Table 108. Bayer Business Overview
Table 109. Bayer Infectious Diseases Product
Table 110. Bayer Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 111. Bayer Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Infectious Diseases Product
Table 115. Bristol-Myers Squibb Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Chimerix Pharmaceuticals Company Details
Table 118. Chimerix Pharmaceuticals Business Overview
Table 119. Chimerix Pharmaceuticals Infectious Diseases Product
Table 120. Chimerix Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 121. Chimerix Pharmaceuticals Recent Development
Table 122. Cubist Company Details
Table 123. Cubist Business Overview
Table 124. Cubist Infectious Diseases Product
Table 125. Cubist Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 126. Cubist Recent Development
Table 127. Eli Lilly Company Details
Table 128. Eli Lilly Business Overview
Table 129. Eli Lilly Infectious Diseases Product
Table 130. Eli Lilly Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 131. Eli Lilly Recent Development
Table 132. Isis Pharmaceuticals Company Details
Table 133. Isis Pharmaceuticals Business Overview
Table 134. Isis Pharmaceuticals Infectious Diseases Product
Table 135. Isis Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 136. Isis Pharmaceuticals Recent Development
Table 137. Mitsubishi Tanabe Pharma Company Details
Table 138. Mitsubishi Tanabe Pharma Business Overview
Table 139. Mitsubishi Tanabe Pharma Infectious Diseases Product
Table 140. Mitsubishi Tanabe Pharma Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 141. Mitsubishi Tanabe Pharma Recent Development
Table 142. Novartis Company Details
Table 143. Novartis Business Overview
Table 144. Novartis Infectious Diseases Product
Table 145. Novartis Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 146. Novartis Recent Development
Table 147. Sanofi Company Details
Table 148. Sanofi Business Overview
Table 149. Sanofi Infectious Diseases Product
Table 150. Sanofi Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 151. Sanofi Recent Development
Table 152. Vertex Company Details
Table 153. Vertex Business Overview
Table 154. Vertex Infectious Diseases Product
Table 155. Vertex Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
Table 156. Vertex Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Diseases Market Share by Type: 2020 VS 2027
Figure 2. Antibacterial Drugs Features
Figure 3. Antiviral Drugs Features
Figure 4. Antifungal Drugs Features
Figure 5. Antiparasitic Drugs Features
Figure 6. Global Infectious Diseases Market Share by Application: 2020 VS 2027
Figure 7. Hospitals/Clinical Laboratories Case Studies
Figure 8. Reference Laboratories Case Studies
Figure 9. Academic/Research Institutes Case Studies
Figure 10. Other Case Studies
Figure 11. Infectious Diseases Report Years Considered
Figure 12. Global Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Infectious Diseases Market Share by Regions: 2020 VS 2027
Figure 15. Global Infectious Diseases Market Share by Regions (2022-2027)
Figure 16. Global Infectious Diseases Market Share by Players in 2020
Figure 17. Global Top Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Infectious Diseases Revenue in 2020
Figure 19. Global Infectious Diseases Revenue Market Share by Type (2016-2021)
Figure 20. Global Infectious Diseases Revenue Market Share by Type (2022-2027)
Figure 21. North America Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Infectious Diseases Market Share by Type (2016-2027)
Figure 23. North America Infectious Diseases Market Share by Application (2016-2027)
Figure 24. North America Infectious Diseases Market Share by Country (2016-2027)
Figure 25. United States Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Infectious Diseases Market Share by Type (2016-2027)
Figure 29. Europe Infectious Diseases Market Share by Application (2016-2027)
Figure 30. Europe Infectious Diseases Market Share by Country (2016-2027)
Figure 31. Germany Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Infectious Diseases Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Infectious Diseases Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Infectious Diseases Market Share by Region (2016-2027)
Figure 41. China Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Infectious Diseases Market Share by Type (2016-2027)
Figure 49. Latin America Infectious Diseases Market Share by Application (2016-2027)
Figure 50. Latin America Infectious Diseases Market Share by Country (2016-2027)
Figure 51. Mexico Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Infectious Diseases Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Infectious Diseases Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Infectious Diseases Market Share by Country (2016-2027)
Figure 57. Turkey Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 61. Gilead Sciences Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 67. Astellas Pharma Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 69. Bayer Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 71. Chimerix Pharmaceuticals Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 72. Cubist Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 74. Isis Pharmaceuticals Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 75. Mitsubishi Tanabe Pharma Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 76. Novartis Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 77. Sanofi Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 78. Vertex Revenue Growth Rate in Infectious Diseases Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の慢性閉塞性肺疾患（COPD）治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into a common chronic disease of cor pulmona and respiratory failure.It is related to the abnormal inflammatory reaction of harmful gases and harmful …- 世界のPOC感染症市場規模・現状・予測（2021年-2027年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…
- 世界の免疫療法用薬市場規模・現状・予測（2021年-2027年） Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system. North America is expected to account for largest share in the …
- 世界の感染症治療市場規模・現状・予測（2021年-2027年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- 世界の治療用酵素薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Therapeutic Enzyme Drugs Market The global Therapeutic Enzyme Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …